Essentials Webinar Series is a programme of 1.5-hour webinars – broadcast live – providing expert specialist clinical training and essential information. These webinars are recorded live and are available for delegates to access freely for six months from the webinar date.
This is the second part of a two part series in which we will discuss
- The signs and symptoms – epidemiological characteristics and key clinical features of main chronic leukaemia types, emphasis on the difference between CML and CLL.
- Significance of early diagnosis and outcomes in chronic leukaemia, including the impact of COVID19 – patient and GP intervals
- Case studies (including exclusion of other blood cancers), typical diagnosis, blood tests and referral.
- Outline of treatment and management of chronic leukaemia
- When active treatment and active monitoring will be used and the impact of each upon patients, plus how to discuss this with patients at point of referral
- Understanding of major treatment approaches in chronic leukaemia, and their side effects
- Holistic care and psychological support, signposting to specific resources
This webinar was created in partnership with Leukaemia Care
- To give specific guidance on interpreting blood counts.
- To provide recommendations on the appropriate referral mechanism for the different suspected diagnoses.
- To raise the index of suspicion for primary care workers for the signs and symptoms, especially when using telephone triage.
- To improve communication and support offered to patients and their families by primary care, particularly for those after treatment or with chronic conditions.
Dr Neil Smith, MBChB (Hons) DCH DCCH DRCOG DFFP MRCGP (Dist) MScGP (Dist)
- Dr Stephen O’Brien, Professor of Haematology Newcastle University Centre for Cancer, Chair, NICE Technology Appraisal Committee C
- Professor Christopher Fegan, Director, School of Medicine, Cardiff University
AiT rate – £15
RCGP Member rate – £20
Non-Member rate – £30